PURPOSE: To evaluate the clinical efficiency, safety and painfulness of retinal laser photocoagulation employing a pattern scanning laser system Pascal given in a single-session versus conventional laser multiple-session treatment of the same patient with diabetic retinopathy during 12-month follow-up. METHODS: The cohort included 60 eyes in 30 patients treated at the Ophthalmology Clinic, Faculty Hospital Ostrava, from 2008 to 2013. Panretinal laser coagulation was performed on one eye using the multispot panretinal photocoagulation given in a single-session system Pascal (OptiMedica, Santa Clara, California). On the other eye laser treatment was carried out by the classic conventional multiple-session method. RESULTS: The performance of Pascal panretinal laser coagulation was evaluated as significantly less painful (visual scale of pain was 3.28 ± 1.9) than the performance of conventional photocoagulation (visual scale of pain was 3.93 ± 1.88) with similar efficiency. Distribution of progression of diabetic retinopathy in individual patients was very similar in both groups under comparison, and was strictly paired in 24 of the 30 patients at the end of 1-year follow-up. CONCLUSION: Laser photocoagulation of the retina with the use of short impulse durations and patterns in patients with diabetic retinopathy given in one session possesses similar efficiency to that of conventional retinal photocoagulation in multiple sessions. The single session treatment is also better tolerated by patients and in addition to this, it shortens the performance of the whole therapy, which potentially saves considerable funds of all subjects participating in the process of treatment. TRIAL REGISTRATION: ClinicalTrials.gov NCT03672656.

Charles University Faculty of Medicine in Hradec Kralove Department of Ophthalmology Hradec Kralove Czech Republic

Faculty Hospital Hradec Kralove Department of Ophthalmology Hradec Kralove Czech Republic

Faculty Hospital Ostrava Department of Ophthalmology Ostrava Czech Republic

University of Ostrava Faculty of Medicine Department of Craniofacial Sciences Ostrava Czech Republic

See more in PubMed

Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema: Early Treatment Diabetic Retinopathy Study Report Number 2. Ophthalmology 1987; 94(7):761–74. PubMed

Early Treatment Diabetic Retinopathy Study Research Group. Techniques for scatter and local photocoagulation treatment of diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report no. 3. Int Ophthalmol Clin 1987; 27(4):54–264, PubMed

Blumenkranz MS, Yellachich D, Andersen DE, Wiltberger MW, Mordaunt D, Marcellino GR, et al. Semiautomated patterned scanning laser for retinal photocoagulation. Retina. 2006; 26(3):370–376. PubMed

American Academy of Ophthalmology Retina Panel Panel. Preffered Practice Pattern® Guidelines. Diabetic Retinopathy. San Francisco, CA: American Academy of Ophthalmology, 2008. [online].

International Council of Ophthalmology | Guidelines for Diabetic Eye Care, 2017. Available from: http://www.icoph.org/enhancing_eyecare/diabetic_eyecare.html

Early Treatment Diabetic Retinopathy Study Research Group. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology 1991; 98(5):741–56. PubMed

Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991; 98(5):766–85. PubMed

The Diabetic Retinopathy Study Research Group. Design, methods, and baseline results. Diabetic Retinopathy Study (DRS) Report Number 6. Invest Ophthalmol Vis Sci 1981; 2: 210–226. PubMed

The Diabetic Retinopathy Study Research Group. A modification of the Airlie House classification of diabetic retinopathy. Diabetic Retinopathy Study (DRS) Report Number 7. Invest Ophthalmol Vis Sci 1981; 21(1):1–226 PubMed

Chappelow AV, Tan K, Waheed NK, Kaiser PK. Panretinal photocoagulation for proliferative diabetic retinopathy: pattern scan laser versus argon laser. Am J Ophthalmol 2012; 153(1):137–42.e2. 10.1016/j.ajo.2011.05.035 PubMed DOI

Jain A, Collen J, Kaines A, Hubschman JP, Schwartz S. Short-duration focal pattern grid macular photocoagulation for diabetic macular edema: four-month outcomes. Retina. 2010; 30(10):1622–6. 10.1097/IAE.0b013e3181e095d8 PubMed DOI

Modi D, Chiranand P, Akduman L. Efficacy of patterned scan laser in treatment of macular edema and retinal neovascularization. Clin Ophthalmol 2009; 3:465–70. 10.2147/opth.s6486 PubMed DOI PMC

Nagpal M, Marlecha S, Nagpal K. Comparison of laser photocoagulation for diabetic retinopathy using 532-nm standard laser versus multispot pattern scan laser. Retina 2010; 30(3):452–8. 10.1097/IAE.0b013e3181c70127 PubMed DOI

Oh JH, Kim SW, Kwon SS, Oh J, Huh K. The change of macular thickness following single-session pattern scan laser panretinal photocoagulation for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2015; 253(1):57–63. 10.1007/s00417-014-2663-x PubMed DOI

Salman AG. Pascal laser versus conventional laser for treatment of diabetic retinopathy. Saudi J Ophthalmol 2011; 25(2):175–9. 10.1016/j.sjopt.2011.01.006 PubMed DOI PMC

Muqit MM, Gray JC, Marcellino GR, Henson DB, Young LB, Patton N, et al. In vivo laser-tissue interactions and healing responses from 20- vs 100-millisecond pulse Pascal photocoagulation burns. Arch Ophthalmol 2010; 128(4):448–55. 10.1001/archophthalmol.2010.36 PubMed DOI

Muqit MM, Gray JC, Marcellino GR, Henson DB, Young LB, Patton N, et al. Single-session vs multiple-session pattern scanning laser panretinal photocoagulation in proliferative diabetic retinopathy: The Manchester Pascal Study. Arch Ophthalmol 2010; 128(5):525–33. 10.1001/archophthalmol.2010.60 PubMed DOI

Muqit MM, Gray JC, Marcellino GR, Henson DB, Young LB, Patton N, et al. Barely visible 10-millisecond pascal laser photocoagulation for diabetic macular edema: observations of clinical effect and burn localization. Am J Ophthalmol 2010; 149(6):979–986.e2. 10.1016/j.ajo.2010.01.032 PubMed DOI

Muqit MM, Gray JC, Marcellino GR, Henson DB, Young LB, Patton N, et al. Pain responses of Pascal 20 ms multi-spot and 100 ms single-spot panretinal photocoagulation: Manchester Pascal Study, MAPASS report 2. Br J Ophthalmol 2010; 94(11):1493–8 10.1136/bjo.2009.176677 PubMed DOI

Muqit MM, Marcellino GR, Henson DB, Young LB, Turner GS, Stanga PE. Pascal Panretinal Laser Ablation and Regression Analysis in Proliferative Diabetic Retinopathy Manchester Pascal Study Report 4. Eye 2011; 25(11):1447–1456. 10.1038/eye.2011.188 PubMed DOI PMC

Muqit MM, Young LB, McKenzie R, John B, Marcellino GR, Henson DB, et al. Pilot randomised clinical trial of Pascal TargETEd Retinal versus variable fluence PANretinal 20 ms laser in diabetic retinopathy: PETER PAN study. Br J Ophthalmol 2013; 97(2):220–7. 10.1136/bjophthalmol-2012-302189 PubMed DOI

Yamakawa M, Nozaki M, Sato R, Morita H, Yoshida M, Ogura Y. Comparison of outcomes of conventional laser versus pascal laser for diabetic retinopathy. Nihon Ganka Gak-kai Zasshi 2014; 118(4):362–7. PubMed

Muraly P, Limbad P, Srinivasan K, Ramasamy K. Single session of Pascal versus multiple sessions of conventional laser for panretinal photocoagulation in proliferative diabetic retinopathy: a comparitive study. Retina 2011; 31(7):1359–65. 10.1097/IAE.0b013e318203c140 PubMed DOI

Ghanchi F: Diabetic Retinopathy Guidelines Working Group. The Royal College of Ophthalmologists' clinical guidelines for diabetic retinopathy: a summary. Eye (Lond) 2013; 27(2):285–7. PubMed PMC

Kalvodova B, Sosna T, Rehak J, Pelikanova T. Practice guidelines for diagnosis and treatment of diabetic retinopathy. Czech Slov Ophthalmol 2012; 68(6):236–41. PubMed

Veith M. Treatment of diabetic macular oedema in a type 1 diabetes patient—mistakes in interdisciplinary collaboration. Internal Medicine. 2013; 59(3):231–3. PubMed

Osaadon P, Fagan XJ, Lifshitz T, Levy J. A review of anti-VEGF agents for proliferative diabetic retinopathy. Eye (Lond) 2014; 28(5): 510–20. PubMed PMC

Nicholson BP, Schachat AP. A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2010; 248(7): 915–30. 10.1007/s00417-010-1315-z PubMed DOI

See more in PubMed

ClinicalTrials.gov
NCT03672656